Ergoteles LLC Ironwood Pharmaceuticals Inc Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $164,496 - $192,096	-13,800 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$10.16 - $13.11 $79,248 - $102,258	-7,800 Reduced 36.11%	13,800 $178,000
Q1 2021 May 12, 2021	BUY	$9.04 - $11.86 $195,263 - $256,176	21,600 New	21,600 $241,000
Q4 2020 Feb 11, 2021	SELL	$9.05 - $12.2 $112,220 - $151,280	-12,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $111,476 - $133,176	12,400 New	12,400 $112,000

236

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $607M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.